Skip to content

Dogwood Therapeutics, Inc.: 10-Q filed 2026-08-14

What Dogwood Therapeutics, Inc. reported in its quarterly report filed 2026-08-14 (fiscal Q2 2026): 42 published measures, 120 facts as tagged in accession 0001104659-26-096719.

This filing

Form
10-Q (quarterly report)
Filed
2026-08-14
Fiscal period
fiscal Q2 2026
Accession
0001104659-26-096719 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Dogwood Therapeutics, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2026-06-3080,495,480USD
At 2025-12-3190,171,237USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2026-06-3012,129,372USD
At 2025-12-3115,274,370USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2026-06-3068,366,108USD
At 2026-03-3180,623,352USD
At 2025-12-3174,896,867USD
At 2025-06-306,878,599USD
At 2025-03-317,086,931USD
At 2024-12-31-10,124,339USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2026-06-309,610,033USD
At 2025-12-316,524,744USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2026-04-01 to 2026-06-30-11,529,609USD91
2026-01-01 to 2026-06-30-16,516,223USD181
2026-01-01 to 2026-03-31-4,986,614USD90
2025-04-01 to 2025-06-30-3,807,353USD91
2025-01-01 to 2025-06-30-14,732,305USD181
2025-01-01 to 2025-03-31-10,924,952USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2026-01-01 to 2026-06-30-8,198,274USD181
2025-01-01 to 2025-06-30-8,708,672USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2026-01-01 to 2026-06-3011,291,348USD181
2025-01-01 to 2025-06-307,252,245USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2026-06-30-124,592,539USD
At 2025-12-31-108,076,316USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2026-04-01 to 2026-06-3034,129,553shares91
2026-01-01 to 2026-06-3033,838,766shares181
2025-04-01 to 2025-06-301,911,128shares91
2025-01-01 to 2025-06-301,680,827shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2026-04-01 to 2026-06-3034,129,553shares91
2026-01-01 to 2026-06-3033,838,766shares181
2025-04-01 to 2025-06-301,911,128shares91
2025-01-01 to 2025-06-301,680,827shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2026-04-01 to 2026-06-30-0.34USD/shares91
2026-01-01 to 2026-06-30-0.49USD/shares181
2025-04-01 to 2025-06-30-1.99USD/shares91
2025-01-01 to 2025-06-30-9.51USD/shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2026-04-01 to 2026-06-30-0.34USD/shares91
2026-01-01 to 2026-06-30-0.49USD/shares181
2025-04-01 to 2025-06-30-1.99USD/shares91
2025-01-01 to 2025-06-30-9.51USD/shares181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2026-06-3012,301USD
At 2025-12-3112,754USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2026-01-01 to 2026-06-30992,622USD181
2025-01-01 to 2025-06-30149,501USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2026-04-01 to 2026-06-30-14,063,525USD91
2026-01-01 to 2026-06-30-19,139,891USD181
2025-04-01 to 2025-06-30-3,923,115USD91
2025-01-01 to 2025-06-30-8,353,041USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2026-06-3011,025,905USD
At 2025-12-318,431,206USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2026-06-302,831,295USD
At 2025-12-313,059,203USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2026-06-30411,516USD
At 2025-12-31760,945USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2026-06-3011,961,275USD
At 2025-12-3112,401,118USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2026-04-01 to 2026-06-3014,063,525USD91
2026-01-01 to 2026-06-3019,139,891USD181
2025-04-01 to 2025-06-303,923,115USD91
2025-01-01 to 2025-06-308,353,041USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2026-04-01 to 2026-06-303,246,519USD91
2026-01-01 to 2026-06-305,916,298USD181
2025-04-01 to 2025-06-302,569,943USD91
2025-01-01 to 2025-06-305,006,941USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2026-06-3033,629,553shares
At 2025-12-3129,743,516shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2026-06-309,610,033USD
At 2025-12-316,524,744USD
At 2025-06-3013,402,809USD
At 2024-12-3114,847,949USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2026-06-30196,246,223USD
At 2025-12-31183,856,376USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2026-06-30-2,991,811USD
At 2025-12-31-587,039USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2026-06-30130,268USD
At 2025-12-31163,140USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2026-06-30127,208USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2026-06-3012,301USD
At 2025-12-3112,754USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2026-06-3057,347,369USD
At 2025-12-3168,985,026USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2026-06-302,352,744USD
At 2025-12-312,241,417USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2026-06-301,415,872USD
At 2025-12-311,906,462USD

Net deferred tax liabilities

Deferred tax liabilities net of related assets under this concept. The amount reflects timing differences and is not tax currently due.

PeriodValueUnitDays
At 2026-06-309,200,344USD
At 2025-12-3112,109,404USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2026-04-01 to 2026-06-30-14,010,303USD91
2026-01-01 to 2026-06-30-18,995,724USD181
2025-04-01 to 2025-06-30-3,807,204USD91
2025-01-01 to 2025-06-30-14,541,614USD181

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2026-01-01 to 2026-06-30-16,516,223USD181
2025-01-01 to 2025-06-30-14,732,305USD181

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2026-04-01 to 2026-06-30-12,800,470USD91
2026-01-01 to 2026-06-30-18,920,995USD181
2025-04-01 to 2025-06-30-272,811USD91
2025-01-01 to 2025-06-30-11,136,607USD181

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2026-04-01 to 2026-06-30-11,529,609USD91
2026-01-01 to 2026-06-30-16,516,223USD181
2025-04-01 to 2025-06-30-3,807,353USD91
2025-01-01 to 2025-06-30-15,988,967USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2026-04-01 to 2026-06-301,626,109USD91
2026-01-01 to 2026-06-304,032,696USD181
2025-04-01 to 2025-06-301,353,172USD91
2025-01-01 to 2025-06-303,346,100USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2025-01-01 to 2025-06-3034,278USD181

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2026-04-01 to 2026-06-3053,222USD91
2026-01-01 to 2026-06-30144,167USD181
2025-04-01 to 2025-06-30115,911USD91
2025-01-01 to 2025-06-30-6,188,573USD181

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2026-04-01 to 2026-06-30-2,480,694USD91
2026-01-01 to 2026-06-30-2,479,501USD181
2025-04-01 to 2025-06-30149USD91
2025-01-01 to 2025-06-30190,691USD181

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2026-04-01 to 2026-06-3031,396USD91
2026-01-01 to 2026-06-3063,080USD181
2025-04-01 to 2025-06-3032,153USD91
2025-01-01 to 2025-06-3063,160USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2026-01-01 to 2026-06-30-325,861USD181
2025-01-01 to 2025-06-30-738,306USD181

Inspect the source

Entity
Dogwood Therapeutics, Inc. / CIK 0001818844
Captured
2026-09-21T17:28:47.393Z
SEC response SHA-256
f281da32357cf25dc41174624e31afea543fa55e9784845d4d35990b5ae1dd70

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001818844.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))